Middle East & Africa In Vitro Lung Model Market Size & Outlook

The in vitro lung model market in Middle East & Africa is expected to reach a projected revenue of US$ 12.5 million by 2030. A compound annual growth rate of 12.1% is expected of Middle East & Africa in vitro lung model market from 2024 to 2030.
Revenue, 2023 (US$M)
$5.6
Forecast, 2030 (US$M)
$12.5
CAGR, 2024 - 2030
12.2%
Report Coverage
Middle East & Africa

MEA in vitro lung model market highlights

  • The MEA in vitro lung model market generated a revenue of USD 5.6 million in 2023.
  • The market is expected to grow at a CAGR of 12.1% from 2024 to 2030.
  • In terms of segment, 2d model was the largest revenue generating type in 2023.
  • 3D Model is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.

MEA data book summary

Market revenue in 2023USD 5.6 million
Market revenue in 2030USD 12.5 million
Growth rate12.1% (CAGR from 2023 to 2030)
Largest segment2d model
Fastest growing segment3D Model
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentation2D Model, 3D Model
Key market players worldwideZoetis, Boehringer Ingelheim, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Kareo, NXGN

Other key industry trends

  • In terms of revenue, MEA region accounted for 1.8% of the global in vitro lung model market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 229.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vitro Lung Model Market Companies

Name Profile # Employees HQ Website

Middle East & Africa in vitro lung model market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro lung model market will help companies and investors design strategic landscapes.


2d model was the largest segment with a revenue share of 55.36% in 2023. Horizon Databook has segmented the Middle East & Africa in vitro lung model market based on 2d model, 3d model covering the revenue growth of each sub-segment from 2018 to 2030.


  • Middle East & Africa In Vitro Lung Model Type Outlook (Revenue, USD Million, 2018-2030)
    • 2D Model
    • 3D Model
  • Middle East & Africa In Vitro Lung Model Application Outlook (Revenue, USD Million, 2018-2030)
    • Drug Discovery and Toxicology Studies
    • Physiological Research
    • 3D Model Development
    • Others
  • Middle East & Africa In Vitro Lung Model End Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Others

Reasons to subscribe to Middle East & Africa in vitro lung model market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa in vitro lung model market databook

  • Our clientele includes a mix of in vitro lung model market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa in vitro lung model market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa in vitro lung model market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA in vitro lung model market report size, by country, 2018-2030 (US$M)

Middle East & Africa In Vitro Lung Model Market Share, 2023 & 2030 (US$M)

MEA in vitro lung model market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more